NASDAQ:PIII

P3 Health Partners (PIII) Stock Price, News & Analysis

P3 Health Partners logo
$2.19 -0.22 (-9.13%)
Closing price 11/17/2026 04:00 PM Eastern
Extended Trading
$2.19 0.00 (0.00%)
As of 03:59 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About P3 Health Partners Stock (NASDAQ:PIII)

Advanced

Key Stats

Today's Range
$2.12
▼
$2.41
50-Day Range
$2.19
▼
$8.43
52-Week Range
$1.52
▼
$16.89
Volume
23,019 shs
Average Volume
57,610 shs
Market Capitalization
$15.90 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$13.67
Consensus Rating
Hold

Company Overview

P3 Health Partners is a physician-led healthcare company focused on helping independent physicians deliver coordinated, value-based care. Its model emphasizes preventive care and managing patients’ overall health, particularly for people enrolled in Medicare Advantage plans.

The company supports participating providers with care coordination, data and technology, clinical resources, and administrative services. It also works with health plans under value-based arrangements, in which care is organized around patient outcomes and quality rather than solely the volume of services provided.

Based in Henderson, Nevada, P3 has operated provider networks in states including Arizona, California, Nevada, Oregon, and Texas. The company became publicly traded in 2021 through a business combination with Foresight Acquisition Corp.

AI Generated. May Contain Errors.

P3 Health Partners Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
34th Percentile Overall Score

PIII MarketRank™: 
1.687783408905 of 5 stars

P3 Health Partners scored higher than 34% of companies evaluated by MarketBeat, and ranked 685th out of 859 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    P3 Health Partners has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, 2 hold ratings, and 1 sell rating.

  • Upside Potential

    P3 Health Partners has a consensus price target of $13.67, representing about 524.0% upside from its current price of $2.19.

  • Amount of Analyst Coverage

    P3 Health Partners has only been the subject of 2 research reports in the past 90 days.

  • Read more about P3 Health Partners' stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of P3 Health Partners is -0.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of P3 Health Partners is -0.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Percentage of Shares Shorted

    0.21% of the float of P3 Health Partners has been sold short.
  • Short Interest Ratio / Days to Cover

    P3 Health Partners has a short interest ratio ("days to cover") of 0.84, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in P3 Health Partners has recently increased by 21.02%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    P3 Health Partners does not currently pay a dividend.

  • Dividend Growth

    P3 Health Partners does not have a long track record of dividend growth.

  • News Sentiment

    P3 Health Partners has a news sentiment score of -0.15. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.56 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for P3 Health Partners this week, compared to 1 article on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, P3 Health Partners insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    10.86% of the stock of P3 Health Partners is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    7.75% of the stock of P3 Health Partners is held by institutions.

  • Read more about P3 Health Partners' insider trading history.
Receive PIII Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for P3 Health Partners and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PIII Stock News Headlines

Pentagon magnet restrictions take effect January 1, 2027
A NASDAQ-listed company has signed a term sheet outlining a potential 75-year agreement with the U.S. Army. It would build and operate a rare earth processing facility on an active military base, with the Army receiving first right to production. The timing matters. New Pentagon restrictions on certain Chinese-origin rare earth magnets take effect January 1, 2027, while China controls more than 90% of global rare earth processing. The company's mine-to-magnet platform spans feedstock agreements, processing facilities, metallization technology, and downstream manufacturing, with initial commercial output targeted for 2027.tc pixel
P3 Health Partners Announces Third Quarter 2026 Results
P3 Health Partners (PIII) Set to Release Earnings on Monday
See More Headlines

PIII Stock Analysis - Frequently Asked Questions

P3 Health Partners' stock was trading at $3.49 at the beginning of the year. Since then, PIII shares have decreased by 37.2% and is now trading at $2.19.

P3 Health Partners Inc. (NASDAQ:PIII) announced its earnings results on Monday, November, 9th. The company reported $0.07 EPS for the quarter, topping analysts' consensus estimates of ($3.96) by $4.03. The firm earned $396.34 million during the quarter, compared to analyst estimates of $384.95 million.
Read the conference call transcript
.

P3 Health Partners's stock reverse split before market open on Monday, April 14th 2025.The 1-50 reverse split was announced on Friday, April 4th 2025. The number of shares owned by shareholders was adjusted after the market closes on Friday, April 11th 2025. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.

P3 Health Partners' top institutional investors include Diversified Trust Co (0.32%). Insiders that own company stock include Pacific Founders Ugp I Chicago and Hudson Vegas Investment Spv, L.
View institutional ownership trends
.

Shares of PIII stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that P3 Health Partners investors own include NVIDIA (NVDA), BigBear.ai (BBAI), Lyra Therapeutics (LYRA), Applied Digital (APLD), Arqit Quantum (ARQQ), Cybin (HELP) and Intel (INTC).

Company Calendar

Last Earnings
11/09/2026
Today
11/18/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Providers & Services
Sub-Industry
Healthcare Services
Current Symbol
NASDAQ:PIII
CIK
1832511
Fax
N/A
Employees
320
Year Founded
N/A

Price Target and Rating

High Price Target
$23.00
Low Price Target
$4.00
Potential Upside/Downside
+524.0%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
4 Analysts

Profitability

EPS (Trailing Twelve Months)
($23.26)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$147.95 million
Net Margins
-3.30%
Pretax Margin
-8.17%
Return on Equity
N/A
Return on Assets
-9.38%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.53
Quick Ratio
0.53

Sales & Book Value

Annual Sales
$1.46 billion
Price / Sales
0.01
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($10.30) per share
Price / Book
-0.21

Miscellaneous

Outstanding Shares
7,260,000
Free Float
6,472,000
Market Cap
$15.90 million
Optionable
Not Optionable
Beta
1.81
10 Best Stocks to Own in Fall 2026 Cover

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report

This page (NASDAQ:PIII) was last updated on 11/17/2026 by MarketBeat.com Staff.
From Our Partners